Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myeloma

Introduction: The appraisal of medicines is often a complex and iterative process. We compared the health technology assessment (HTA) process in England and France taking as a case study the example of ixazomib for multiple myeloma. Methods: We undertook an analysis of eight relevant published docum...

Descripción completa

Detalles Bibliográficos
Autores principales: Armoiry, Xavier, Spath, Hans-Martin, Clarke, Aileen, Connock, Martin, Sutcliffe, Paul, Dussart, Claude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711145/
https://www.ncbi.nlm.nih.gov/pubmed/31489149
http://dx.doi.org/10.1080/20016689.2019.1648971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711145/
https://www.ncbi.nlm.nih.gov/pubmed/31489149
http://dx.doi.org/10.1080/20016689.2019.1648971

Ejemplares similares